Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.

Hemel Hempstead, GB
Size (employees)
2,098 (est)+6%
Consort Medical is headquartered in Hemel Hempstead, GB
Report incorrect company information

Consort Medical Office Locations

Consort Medical has offices in Hemel Hempstead, Cambridge, Northumberland, North Lynn Industrial Estate and in 7 other locations
Hemel Hempstead, GB (HQ)
Breakspear Way
Cambridge, GB
Newmarket Rd
Nelson, GB
Edward St
North Lynn Industrial Estate, GB
Bergen Way
Northumberland, GB
Shotton Ln
Queenborough, GB
North Rd
Show all (11)
Report incorrect company information

Consort Medical Financials and Metrics

Consort Medical Financials

Consort Medical's revenue was reported to be £276.91 m in FY, 2016 which is a 49.8% increase from the previous period.

Revenue (FY, 2016)

276.9 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

16 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

16 m

Market capitalization (31-Oct-2017)

542.9 m

Closing share price (31-Oct-2017)


Cash (30-Apr-2016)

16.3 m
Consort Medical's current market capitalization is £542.9 m.
GBPFY, 2014FY, 2015FY, 2016


100 m184.8 m276.9 m

Revenue growth, %


Cost of goods sold

176.7 m261 m

Gross profit

8.2 m16 m
GBPFY, 2014FY, 2015FY, 2016


25.8 m45.2 m16.3 m

Accounts Receivable

13.6 m47 m45.2 m

Current Assets

64 m139.1 m110.9 m


58.9 m135.3 m144.9 m
GBPFY, 2014FY, 2015FY, 2016

Cash From Operating Activities

13.8 m12.1 m37.4 m

Cash From Financing Activities

(8.4 m)231.6 m(45.9 m)

Income Taxes Paid

(2.5 m)750 k4.7 m
GBPY, 2016


140.3 k

Financial Leverage

2.1 x
Show all financial metrics
Report incorrect company information